Alivecor gets a green light from FDA to screen for dangerously high potassium levels in the blood
The U.S. Food and Drug Administration has granted AliveCor the designation of ‘breakthrough device’ for it’s ability to detect a rare but dangerous blood condition called hyperkalemia without taking any blood from the patient.
